<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=138881"><dc:title>Induced pluripotent stem cell (iPSC) line MLi004-A derived from a patient with recessive dystrophic epidermolysis bullosa (RDEB)</dc:title><dc:creator>Ropret,	Sandra	(Avtor)
	</dc:creator><dc:creator>Jeriha,	Jakob	(Avtor)
	</dc:creator><dc:creator>Sorčan,	Tjaša	(Avtor)
	</dc:creator><dc:creator>Rogar,	Marija	(Avtor)
	</dc:creator><dc:creator>Zemljič,	Špela	(Avtor)
	</dc:creator><dc:creator>McGrath,	John A.	(Avtor)
	</dc:creator><dc:creator>Ilic,	Dusko	(Avtor)
	</dc:creator><dc:creator>Liović,	Mirjana	(Avtor)
	</dc:creator><dc:subject>stem cell</dc:subject><dc:subject>epidermolysis</dc:subject><dc:subject>collagen VII</dc:subject><dc:subject>recessive dystrophic EB</dc:subject><dc:subject>iPSC line</dc:subject><dc:subject>pluripotency</dc:subject><dc:subject>fibroblast</dc:subject><dc:subject>keratinocyte</dc:subject><dc:description>We have generated MLi004-A, a new induced pluripotent stem cell (iPSC) line derived from skin fibroblasts of a female patient with recessive dystrophic epidermolysis bullosa (RDEB). This iPSC line may be used as a model system for studies on skin integrity, the extracellular matrix and skin barrier function. The characterization of the MLi004-A cell line consisted of molecular karyotyping, next-generation sequencing of the COL7A1 alleles, plu-ripotency and differentiation potentials testing by immunofluorescence of associated markers in vitro. The MLi004-A line has been also tested for ability to differentiate into fibroblasts.</dc:description><dc:date>2021</dc:date><dc:date>2022-08-24 11:04:02</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>138881</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>